DrugDashboards

Anagrelide

Anagrelide · ANAGRELIDE HYDROCHLORIDE 1 mg/1 · Capsule · Oral · ANI Pharmaceuticals, Inc.

NDC 70954-0881-10 · 100 CAPSULE in 1 BOTTLE · ANDA · View full market →

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$1.00$2.00Dec 2025Sep 2026$1.44
9 price points · per EASource: CMS NADAC

Estimated fill cost

#30 count
$43.22
#90 count
$129.67

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Supply fragility

10Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 3 active manufacturers+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for anagrelide (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA076811
TE code
AB
Approval date
Apr 18, 2005
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Anagrelide (Capsule)

LabelerStrengthFirst seenLast seen
ANI Pharmaceuticals, Inc.ANAGRELIDE HYDROCHLORIDE .5 mg/1Jul 15, 2026Sep 2, 2026
ANI Pharmaceuticals, Inc.ANAGRELIDE HYDROCHLORIDE 1 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCANAGRELIDE HYDROCHLORIDE ANHYDROUS .5 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCANAGRELIDE HYDROCHLORIDE ANHYDROUS 1 mg/1Jul 15, 2026Sep 2, 2026
Torrent Pharmaceuticals LimitedANAGRELIDE HYDROCHLORIDE ANHYDROUS .5 mg/1Jul 15, 2026Sep 2, 2026
Torrent Pharmaceuticals LimitedANAGRELIDE HYDROCHLORIDE ANHYDROUS 1 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Anagrelide — NDC 70954-0881-10," retrieved September 3, 2026, https://drugdashboards.com/drug/70954088110.

Free to cite with attribution — see how the data is put together.